Archon emerges from stealth with $20M and ‘antibody cages’ to power up drug development ...Middle East

Archon Biosciences, a biotech startup putting AI to work designing novel biomolecules, has just emerged from stealth with an impressive $20 million in seed funding. The company aims to supercharge antibody treatments using specially designed protein “cages” that multiply their effects, opening up new opportunities in drug development. This is the first company to be […] © 2024 TechCrunch. All rights reserved. For personal use only.

Read More Details
Finally We wish PressBee provided you with enough information of ( Archon emerges from stealth with $20M and ‘antibody cages’ to power up drug development )

Also on site :

• Trump cuts tariffs on U.K. cars, steel and aluminum but keeps 10% base duty while Britain trims its taxes on 2,500 U.S. products
• Three big clues about new Pope Leo XIV’s papacy in opening speech
• ‘Shadow Force’ Review: Two Spies Get Dragged From the Cold in Middling Action Opus